Atreca Inc Class A (OTC:BCEL) Stock, Quote.Headers.trade-ideas

Atreca

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATRA

BCEL

BETS

BIOR

CAMP

CANO

CCTG

CHEA

CVKD

DCFC

FDMT

GRDI

MEGL

NEXI

NSTG

TWOU

WORX

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading.

4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability &amp; clinical activity in wet AMD.

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Earnings

Eurozone

Commodities

Global

Intraday Update

DATS

Airspan Networks Holdings Inc. Common Stock

MIMO

PHUN

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Wednesday.

The Dow traded down 0.04% to 37,345.91 while the NASDAQ fell 0.86% to 14,815.87. The S&amp;P 500 also fell, dropping, 0.47% to 4,743.45.

Gold Moves Lower; Phunware Shares Plummet

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 200 points on Wednesday.

Following the market opening, the Dow traded down 0.26% to 37,264.12 while the NASDAQ fell 1.54% to 14,714.00. The S&amp;P 500 also fell, dropping, 0.81% to 4,727.51.

Nasdaq Down Over 200 Points; US Retail Sales Increase 0.6% In December

Atreca Inc Class A

Contracts

VRAR

The Glimpse Group Partners With The College Of Staten Island To Provide Technologies For Innovation Hub; Entered Into Two-Year Mix-Six Figure Contract

SRZN

Surrozen Earns $10M Milestone Payment As Boehringer Advances Development Of SZN-413 For Retinal Vascular Diseases, Prepares For Clinical Testing

Legal

VTAK

Catheter Precision Received Chinese Patent For LockeT

UGRO

urban-gro Wins Contract For Architectural Design Services For University Student Center Renovation At Columbia State University; Terms Not Disclosed

Piper Sandler analyst Michael Lavery maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Overweight and lowers the price target from $50 to $47.

Price Target

Analyst Ratings

CELH

Piper Sandler Maintains Overweight on Celsius Holdings, Lowers Price Target to $47

CRH PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) company disclosed that its CEO Albert Manifold <a href="https://www.benzinga.com/pressreleases/24/09/b40995127/crh-announces-ceo-succession" target="_blank" rel="noreferrer noopener">will retire at the end of 2024</a>.
Manifold will be succeeded by Jim Mintern, CRH&#8217;s Chief Financial Officer and board director since June 2021.
Manifold, who joined CRH in 1998 and became CEO in January 2014, will step down from the board and his executive responsibilities on December 31, 2024.
Richie Boucher, Chairman of CRH, said, &#8220;The Board has a significant focus on succession planning throughout CRH. With the support of independent advisors, we have followed best practice, including a review of external candidates, and we have carefully monitored the development plans for potential internal candidates.&#8221;
&#8220;Over recent years we have closely observed Jim&#8217;s character, qualities and abilities, as well as his significant influence on the evolution of CRH. We are very pleased to have a successor of such caliber and are confident that Jim is best positioned to lead the CRH team, building the future of the company for the benefit of our investors, customers, colleagues and communities.&#8221;
Investors can gain exposure to the stock via Invesco Building &amp; Construction ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKB#NYSE">PKB</a>) and Fidelity MSCI Materials Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMAT#NYSE">FMAT</a>).
Price Action: CRH shares are down 0.94% at $91.11 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40999268" target="_blank" rel="noreferrer noopener">Tesla Stock Poised For More Gains After Erasing Losses For The Year: What&#8217;s Charging Up The EV Maker?</a></li>
</ul>

Equities

Large Cap

Management

FMAT

PowerShares ETF Trust Dynamic Building &nstruction Portfolio

Big Changes At Building Products Company CRH: CEO Albert Manifold Set To Retire, CFO Jim Mintern Gears Up To Lead In 2025

BNZI

Banzai Announces $24.8M Debt Payoff And Restructuring Agreements With Insider Participation, Reducing Debt Burden And Extending Maturity To 2027

Granite Awarded $113M Contract To Support U.S. Marines Relocation

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://widgets.benzinga.com/analyst-stock-ratings/analyst/60f00f67c9514d0001c5b305/charlene-liu">HSBC analyst Charlene Liu</a> downgraded the rating for Baidu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) from Buy to Hold and announced a price target of $100. Baidu shares gained 2.4% to close at $88.28 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other </a><a href="https://www.benzinga.com/quote/bidu/analyst-ratings">analysts </a><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">view this stock</a>.</li>
<li>Redburn Atlantic analyst Peter Low downgraded the rating for BP p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) from Buy to Neutral. BP shares gained 0.7% to close at $32.86 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this </a><a href="https://www.benzinga.com/quote/BP/analyst-ratings">stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58933b2043eaaa0001698f4c/eric-coldwell">Baird analyst Eric Coldwell </a>downgraded McKesson Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) from Outperform to Neutral and lowered the price target from $603 to $531. McKesson shares fell 0.6% to close at $505.00 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See</a><a href="https://www.benzinga.com/quote/MCK/analyst-ratings"> </a><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">how other analysts view this stock</a>.</li>
<li>Leerink Partners analyst Andrew Berens downgraded the rating for Regeneron Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) from Outperform to Market Perform, while cutting the price target from $1,175 to $1,077. Regeneron Pharmaceuticals shares fell 4.6% to close at $1,091.98 on Monday. <a href="https://www.benzinga.com/quote/REGN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59c264af6e84a70001eb1bb8/david-chiaverini">Wedbush analyst David Chiaverini </a>downgraded First Horizon Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) from Outperform to Neutral and slashed the price target from $20 to $17. First Horizon shares fell 1.9% to close at $15.67 on Monday. <a href="https://www.benzinga.com/quote/FHN/analyst-ratings">See </a><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">how other analysts view this stock</a>.</li>
</ul>
Considering buying BP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image is-resized"><img decoding="async" src="blob:https://editorial.benzinga.com/c9689ca0-032e-42a9-818e-8c799d42f940" alt="" style="width:618px;height:auto" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40991631/jim-cramer-says-this-utilities-stock-is-a-buy-we-need-cheap-power">Jim Cramer Says This Utilities Stock Is A Buy: &#8216;We Need Cheap Power&#8217;</a></li>
</ul>

Downgrades

BIDU

REGN

This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Companies Targeting Closing in Fourth Quarter of 2024
Aditxt, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) ("Aditxt" or the "Company"), an innovation platform dedicated to accelerating promising health innovations, today announced that its acquisition target, Evofem Biosciences, Inc. ("Evofem") (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/EVFM#OTCQB">EVFM</a>), today filed a <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fapp.quotemedia.com%2Fdata%2FdownloadFiling%3FwebmasterId%3D101533%26ref%3D318604913%26type%3DHTML%26symbol%3DEVFM%26cdn%3Daa965ae7d29bd4fb48009ea93f2217c9%26companyName%3DEvofem%2BBiosciences%2BInc.%26formType%3DPRE%2B14A%26dateFiled%3D2024-09-23&amp;esheet=54126410&amp;newsitemid=20240924145198&amp;lan=en-US&amp;anchor=preliminary+proxy&amp;index=1&amp;md5=db30e6831fb84e7ccf45f998ac0d37d0">preliminary proxy</a> to seek stockholder approval of transactions contemplated under the Amended and Restated Merger Agreement dated as of July 12, 2024 (the "Merger Agreement"), with Aditxt and Adifem, Inc., a wholly-owned subsidiary of Aditxt ("Adifem"), pursuant to which, and on the terms and subject to the conditions thereof, Adifem will merge with and into Evofem, with Evofem surviving as a wholly owned subsidiary of Aditxt.
Assuming the proposal is approved by Evofem stockholders and other closing conditions are met, including but not limited to the Company raising sufficient capital to fund its obligations at closing, the companies are targeting closing the transaction in the fourth quarter of 2024. No assurance can be provided that all of the conditions to closing will be obtained or satisfied or that either of the transactions will ultimately close.

ADTX

EVFM

Evofem Biosciences Files Preliminary Proxy For Stockholder Approval Of The Acquisition By Aditxt, Companies Targeting Closing In Q4 Of 2024

LPTH

LightPath Technologies Secures $3.5M Follow-On Order To Provide Advanced Infrared Optics For F-35 Combat Aircraft Program

Piper Sandler analyst Korinne Wolfmeyer initiates coverage on Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Neutral rating and announces Price Target of $174.

Initiation

Piper Sandler Initiates Coverage On Procter & Gamble with Neutral Rating, Announces Price Target of $174

Cantor Fitzgerald analyst Charles Duncan reiterates Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) with a Overweight and maintains $13 price target.

Reiteration

MRNS

Cantor Fitzgerald Reiterates Overweight on Marinus Pharma, Maintains $13 Price Target

<ul>
<li>An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials.</li>
<li>The DSMB Recommended Both Phase 3 Trials Continue as Planned, Without Modification.
<ul>
<li>Final Clinical Safety Data for Simufilam Are Expected at the Conclusion of the Phase 3 Program. &nbsp;</li>
</ul>
</li>
</ul>

Biotech

General

SAVA

Cassava Sciences Completes Interim Safety Review Of Oral Simufilam On-Going Phase 3 Trials

Aurinia Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUPH#NASDAQ">AUPH</a>) (Aurinia or the Company) today announced that the Japanese Ministry of Health, Labour, and Welfare has approved voclosporin, a second-generation calcineurin inhibitor, in combination with mycophenolate mofetil (MMF) to treat lupus nephritis (LN).
The Company's collaboration partner, Otsuka Pharmaceutical Co., Ltd., filed the new drug application (NDA) with Japanese regulatory authorities in November 2023. The approval is based on data from the AURORA Clinical Program, which included a 12-month, Phase 3, double-blind, randomized-controlled study, as well as a two-year extension study, assessing the efficacy and safety of voclosporin with MMF and low-dose glucocorticoids, compared to MMF and low-dose glucocorticoids alone, in LN patients.

AUPH

Aurinia Announces Japan Approval Of LUPKYNIS To Treat Lupus Nephritis

ANIX

Anixa Biosciences Announces Phase 2 Study Plan for Breast Cancer Vaccine; Phase 2 Trial Will Evaluate Efficacy Of Vaccine Administered In The Neoadjuvant Setting In Combination With Keytruda And Chemotherapy

WIIM

CRMT

America's Car-Mart shares are trading higher after the company appointed Jamie Fischer as COO.

Piper Sandler analyst Korinne Wolfmeyer initiates coverage on Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Overweight rating and announces Price Target of $121.

Piper Sandler Initiates Coverage On Colgate-Palmolive with Overweight Rating, Announces Price Target of $121

Arlo Secure Subscription Plans Feature New Proprietary AI Technology to Provide Personalized Protection
SAN JOSE, Calif., Sept. 24, 2024 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4261725-1&amp;h=186870682&amp;u=http%3A%2F%2Fwww.arlo.com%2F&amp;a=Arlo+Technologies%2C+Inc">Arlo Technologies, Inc</a>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARLO#NYSE">ARLO</a>), a leading smart home security brand, today announced Arlo Secure 5, the next generation of smart home security powered by Arlo Intelligence (AI). Arlo's new proprietary AI technology introduces a suite of industry-first features such as custom detections, vehicle recognition and person recognition. Arlo Secure 5 further builds upon Arlo's values to connect and protect what users love most by adding truly customized security solutions that offer more personalized control.

ARLO

Arlo Announces Secure 5, Next Generation Of Smart Home Security Powered By Arlo Intelligence; Arlo Secure Subscription Plans Feature New Proprietary AI Technology To Provide Personalized Protection

Cantor Fitzgerald analyst Charles Duncan reiterates Biohaven (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHVN#NYSE">BHVN</a>) with a Overweight.

BHVN

Cantor Fitzgerald Reiterates Overweight on Biohaven

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!



Moving stocks are investments, acquisitions, share repurchase programs and more.



Let&rsquo;s get into that new



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Atreca (NASDAQ:<a href="https://investorplace.com/stock-quotes/bcel-stock-quote/">BCEL</a>) stock is rocketing more than 98% as Baker Bros. Advisors LP takes a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317979722&amp;type=PDF&amp;symbol=BCEL&amp;cdn=1b0879319fa57b56e7f6cf144646901f&amp;companyName=Atreca+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-01-10">nearly 20% stake</a> in the company.</li>



<li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) shares are soaring 46% with heavy pre-market trading.</li>



<li>Transphorm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tgan-stock-quote/">TGAN</a>) stock is surging over 30% as Renesas Electronics <a href="https://www.nasdaq.com/press-release/renesas-to-acquire-transphorm-to-expand-its-power-portfolio-with-gan-technology-2024">plans to acquire the company</a>.</li>



<li>Marti Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mrt-stock-quote/">MRT</a>) shares are gaining more than 24% on a <a href="https://www.nasdaq.com/press-release/marti-announces-up-to-%242.5m-share-repurchase-program-2024-01-10">$2.5 million share repurchase program</a>.</li>



<li>Eightco (NASDAQ:<a href="https://investorplace.com/stock-quotes/octo-stock-quote/">OCTO</a>) stock is increasing over 18% on Thursday morning.</li>



<li>Ekso Bionics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ekso-stock-quote/">EKSO</a>) shares are rising more than 18% alongside <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317979865&amp;type=PDF&amp;symbol=EKSO&amp;cdn=90445955b23707c0858f19acaf1462c5&amp;companyName=Ekso+Bionics+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-01-10">a new filing</a>.</li>



<li>iShares iBonds Dec 2028 Term Treasury ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/ibti-stock-quote/">IBTI</a>) stock is climbing 18% on Thursday morning.</li>



<li>Altamira Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyto-stock-quote/">CYTO</a>) shares are jumping over 16% without any clear news.</li>



<li>Srivaru (NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/">SVMH</a>) stock is getting a more than 14% boost today. </li>



<li>Avalo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/avtx-stock-quote/">AVTX</a>) shares are up over 14% on Thursday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Greenbrook TMS (NASDAQ:<a href="https://investorplace.com/stock-quotes/gbnh-stock-quote/">GBNH</a>) stock is diving more than 24% without any apparent news today.</li>



<li>180 Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/atnf-stock-quote/">ATNF</a>) shares are tumbling over 21% despite a lack of news.</li>



<li> Tarena International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCTM#NASDAQ">TCTM</a>) stock is taking a more than 15% beating after <a href="https://finance.yahoo.com/news/tarena-change-ticker-symbol-ring-110000763.html">changing its ticker yesterday</a>.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) shares are dropping over 13% on Thursday morning.</li>



<li>Clearmind Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmnd-stock-quote/">CMND</a>) stock is sliding close to 13% <a href="https://investorplace.com/2024/01/why-is-clearmind-cmnd-stock-up-40-today/">following a rally on Wednesday</a>.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares are decreasing almost 12% today.</li>



<li>PAVmed (NASDAQ:<a href="https://investorplace.com/stock-quotes/pavm-stock-quote/">PAVM</a>) stock is declining nearly 12% on Thursday.</li>



<li>Multi Ways (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mwg-stock-quote/">MWG</a>) shares are slipping close to 11% today.</li>



<li>Vyne Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vyne-stock-quote/">VYNE</a>) stock is dipping more than 10% this morning.</li>



<li>Greenwave Technology Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/gwav-stock-quote/">GWAV</a>) shares close out our pre-market stock movers down over 10%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



<ol></ol><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-jan-11th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Atreca&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bcel-stock-quote/">BCEL</a>) stock is rising higher on Thursday following news of a major stake in the clinical-stage biopharmaceutical company from an investment advisor.



According to a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317979722&amp;type=PDF&amp;symbol=BCEL&amp;cdn=1b0879319fa57b56e7f6cf144646901f&amp;companyName=Atreca+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-01-10">filing with the Securities and Exchange Commission</a> (SEC), Baker Bros. Advisors LP now holds a 19.9% stake in the company. This comes through a mix of Class A shares of BCEL stock and Class B shares that can be converted to Class A shares.



Atreca&nbsp;notes that the ability to convert Class B shares to Class A shares with a limitation of a 19.99% stake in the company will go into effect on Feb. 21, 2024. Prior to this, Baker Bros. Advisors LP was limited to holding a 4.99% stake in the company.



<h2>How This Affects BCEL Stock Today</h2>



Investors are seeing heavy trading of BCEL stock on Thursday alongside the Baker Bros. Advisors LP stake news. That has more than 20 million shares of the stock changing hands as of this writing. That&rsquo;s already well above the company&rsquo;s daily average trading volume of about 2.6 million shares.



BCEL stock is up 84.6% as of Thursday morning.



Investors who are searching for more of the most recent stock market news are in luck!



We have all of the latest stock market stories worth reading about on Thursday! That includes the biggest pre-market stock movers this morning, the latest news concerning Mullen Automotive&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/muln-stock-quote/">MULN</a>) stock and more. All of that news is ready to go at the links below!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-jan-11th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>



<li><a href="https://investorplace.com/2024/01/muln-stock-mullen-seeks-50-million-loan-from-department-of-energy/">MULN Stock: Mullen Seeks $50 Million Loan from Department of Energy</a></li>



<li><a href="https://investorplace.com/2024/01/rum-stock-alert-the-sec-is-investigating-rumble/">RUM Stock Alert: The SEC Is Investigating Rumble</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/why-is-atreca-bcel-stock-up-85-today/">Why Is Atreca (BCEL) Stock Up 85% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Atreca (BCEL) Stock Up 85% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Tarena International&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tctm-stock-quote/">TCTM</a>) stock is falling on Thursday just one day after the professional education services company <a href="https://finance.yahoo.com/news/tarena-change-ticker-symbol-ring-110000763.html">changed the ticker for its shares</a>.



Tarena International started trading on Wednesday with its shares trading under the current TCTM stock ticker. Before that, shares of the company&rsquo;s stock were trading under the TEDU sticker.



The change in stock tickers also comes alongside a shift in exchanges. That saw the company&rsquo;s stock move from the Nasdaq Global Market to the Nasdaq Capital Markets as well yesterday.



Ying Sun, the CEO of Tarena International, said the following about the stock ticker change yesterday.




&ldquo;On the momentous occasion of our new start, ringing the Nasdaq opening bell symbolizes our sustained dedication to advancing our course offerings, cultivating premium services and upgrading our operations to face the challenges and opportunities in wider market prospects.&rdquo;




<h2>TCTM Stock Movement</h2>



Yesterday&rsquo;s stock ticker and exchange change brought extra attention to TCTM stock. That resulted in the shares gaining 20.3% during normal trading hours. It also came with about 1 million shares changing hands.



Shares of TCTM stock are giving up some of that momentum with a 10.3% fall on Thursday morning. That comes as around 6,000 shares change hands. For the record, the company&rsquo;s daily average trading volume is about 27,000 shares.



There are even more stock market stories traders are going to want to read about below!



We have all of the hottest stock market news worth reading about on Thursday! A few examples include what has shares of Moolec Science&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) and Atreca&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bcel-stock-quote/">BCEL</a>) stock up today, as well as the biggest pre-market stock movers this morning. All of that news is ready to go at the following links!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/01/why-is-moolec-science-mlec-stock-up-40-today/">Why Is Moolec Science (MLEC) Stock Up 40% Today?</a></li>



<li><a href="https://investorplace.com/2024/01/why-is-atreca-bcel-stock-up-85-today/">Why Is Atreca (BCEL) Stock Up 85% Today?</a></li>



<li><a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-jan-11th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/why-is-tarena-international-tctm-stock-down-10-today/">Why Is Tarena International (TCTM) Stock Down 10% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Tarena International (TCTM) Stock Down 10% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Clearmind Medicine&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/cmnd-stock-quote/">CMND</a>)&nbsp;stock is slipping on Thursday after the psychedelics pharmaceutical company&rsquo;s shares <a href="https://investorplace.com/2024/01/why-is-clearmind-cmnd-stock-up-40-today/">underwent a major rally on Wednesday</a>.



The news that sent shares of CMND stock higher yesterday was a meeting with the Food and Drug Administration (FDA). The company is seeking to treat Alcohol Use Disorder with a clinical trial of its psychedelics.



News of that meeting spurred an interest in CMND stock on Wednesday. That saw the company close out normal trading hours up 41.6%. That came with some 47 million shares traded compared to a daily average of 1.9 million shares.



<h2>CMND Stock Movement on Thursday</h2>



Even though the stock rallied yesterday it can&rsquo;t maintain all of those gains today. That&rsquo;s why shares are falling 23.9% as of Thursday morning. That comes alongside some 721,000 shares of CMND stock being traded at that same time.



One thing that investors will keep in mind about CMND is that it is a penny stock. That comes from its closing price of $2.93 and market capitalization of only $5.141 million. That means the stock is more susceptible to strong volatility and makes it a riskier investment.



There&rsquo;s plenty of other stock market stories worth reading about today that don&rsquo;t have to do with CMND stock.



Fortunately, we have investors covered with our coverage of the latest market happenings! That includes what&rsquo;s going on with shares of Tarena International&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tctm-stock-quote/">TCTM</a>) stock, Moolec Science&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>)&nbsp;stock and Atreca&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bcel-stock-quote/">BCEL</a>) stock today. You can find out more on these matters down below!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/01/why-is-tarena-international-tctm-stock-down-10-today/">Why Is Tarena International (TCTM) Stock Down 10% Today?</a></li>



<li><a href="https://investorplace.com/2024/01/why-is-moolec-science-mlec-stock-up-40-today/">Why Is Moolec Science (MLEC) Stock Up 40% Today?</a></li>



<li><a href="https://investorplace.com/2024/01/why-is-atreca-bcel-stock-up-85-today/">Why Is Atreca (BCEL) Stock Up 85% Today?</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/why-is-clearmind-medicine-cmnd-stock-down-24-today/">Why Is Clearmind Medicine (CMND) Stock Down 24% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Clearmind Medicine (CMND) Stock Down 24% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Moolec Science&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is getting a boost on Thursday despite a lack of news from the science-based <a href="https://moolecscience.com/">food ingredient company</a>.



There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is rising today. On that same note, no analysts are offering new coverage that would give a reason for today&rsquo;s rally.



Even without news the company&rsquo;s shares are experiencing heavy trading on Thursday. As of this writing, more than 6.8 million shares of Moolec Science stock have changed hands. That&rsquo;s a massive jump compared to the daily average trading volume of around 5,000 shares for MLEC stock.



One thing that investors will want to keep in mind is Moolec Science&rsquo;s shares being a penny stock. That comes from its low trading volume, closing price of $2 and its market capitalization of about $85.613 million.



<h2>What That Means for MLEC Stock</h2>



Being a penny stock opens Moolec Science up to certain vulnerabilities. That includes manipulation from certain traders that would seek to pump and dump its shares.



Considering the wild movement MLEC stock is seeing today, a pump may be underway. If so, investors will want to avoid taking a stake in Moolec Science shares right now to avoid that potential dump.



MLEC stock is up 40.4% as of Thursday morning.



Investors looking for more of the most recent stock market stories are in the right place!



InvestorPlace is home to all of the hottest stock market stories traders need to know about on Thursday! Among that is what&rsquo;s happening with Atreca&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bcel-stock-quote/">BCEL</a>) stock, the biggest pre-market movers this morning and more. All of that news is available at the following links!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/01/why-is-atreca-bcel-stock-up-85-today/">Why Is Atreca (BCEL) Stock Up 85% Today?</a></li>



<li><a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-jan-11th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>



<li><a href="https://investorplace.com/2024/01/muln-stock-mullen-seeks-50-million-loan-from-department-of-energy/">MULN Stock: Mullen Seeks $50 Million Loan from Department of Energy</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/why-is-moolec-science-mlec-stock-up-40-today/">Why Is Moolec Science (MLEC) Stock Up 40% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Moolec Science (MLEC) Stock Up 40% Today?

Sera Prognostics, Atreca spike after Baker Bros investments

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We&rsquo;re starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!



Moving stocks this morning are low natural gas prices, shareholder meeting results and more.



Let&rsquo;s go over that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Rail Vision (NASDAQ:<a href="https://investorplace.com/stock-quotes/rvsn-stock-quote/">RVSN</a>) stock is rocketing more than 79% alongside heavy pre-market trading.</li>



<li>Phunware (NASDAQ:<a href="https://investorplace.com/stock-quotes/phun-stock-quote/">PHUN</a>) shares are increasing over 67% with strong early morning trading.</li>



<li>MariaDB (NYSE:<a href="https://investorplace.com/stock-quotes/mrdb-stock-quote/">MRDB</a>) stock is gaining more than 17% on Tuesday morning.</li>



<li>AdvisorShares Trust AdvisorShares MSOS 2x Daily ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/msox-stock-quote/">MSOX</a>) shares are surging over 17% today.</li>



<li>ProShares UltraShort Bloomberg Natural Gas (NYSEARCA:<a href="https://investorplace.com/stock-quotes/kold-stock-quote/">KOLD</a>) stock is rising more than 17% as <a href="https://www.wsj.com/finance/commodities-futures/natural-gas-prices-remain-under-pressure-despite-cold-snap-25c33973">gas prices are still under pressure</a>.</li>



<li>MorphoSys (NASDAQ:<a href="https://investorplace.com/stock-quotes/mor-stock-quote/">MOR</a>) shares are heading close to 17% higher on Tuesday.</li>



<li>Companhia Brasileira (NYSE:<a href="https://investorplace.com/stock-quotes/cbd-stock-quote/">CBD</a>) stock is climbing over 16% alongside <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317985522&amp;type=PDF&amp;symbol=CBD&amp;cdn=25dfaceac8a47ba24177d0c57013039f&amp;companyName=Companhia+Brasileira+de+Distribuicao+American+Depsitary+Shares%3B+each+representing+one&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-01-16">details of its general shareholder meeting</a>.</li>



<li>Akso Health Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/ahg-stock-quote/">AHG</a>) shares are getting a more than 15% boost without any clear news.</li>



<li>Infrared Cameras (NASDAQ:<a href="https://investorplace.com/stock-quotes/msai-stock-quote/">MSAI</a>) stock is jumping over 14% on Tuesday morning.</li>



<li>LQR House (NASDAQ:<a href="https://investorplace.com/stock-quotes/lqr-stock-quote/">LQR</a>) shares are up more than 11% on Tuesday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Srivaru (NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/">SVMH</a>) stock is diving over 21% following a Friday rally.</li>



<li>Ault Alliance (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ault-stock-quote/">AULT</a>) shares are tumbling more than 21% after <a href="https://www.nasdaq.com/press-release/ault-alliance-announces-results-of-annual-meeting-of-stockholders-2024-01-12">posting results from a shareholder meeting</a>.</li>



<li>Atreca (NASDAQ:<a href="https://investorplace.com/stock-quotes/bcel-stock-quote/">BCEL</a>) stock is taking an over 18% beating after rallying on Friday.</li>



<li>Nuburu (NYSEMKT:<a href="https://investorplace.com/stock-quotes/buru-stock-quote/">BURU</a>) shares are sliding more than 18% following a recent rally.</li>



<li>ProShares Ultra Bloomberg Natural Gas (NYSEARCA:<a href="https://investorplace.com/stock-quotes/boil-stock-quote/">BOIL</a>) stock is falling over 16% with low gas prices.</li>



<li>Neptune Wellness Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/nept-stock-quote/">NEPT</a>) shares are dropping more than 15% this morning.</li>



<li>Nubia Brand International (NASDAQ:<a href="https://investorplace.com/stock-quotes/nubi-stock-quote/">NUBI</a>) stock is decreasing over 15% this morning.</li>



<li>Charge Enterprises (NASDAQ:<a href="https://investorplace.com/stock-quotes/crge-stock-quote/">CRGE</a>) shares are declining nearly 15% after a massive rally on Friday.</li>



<li>Applied UV (NASDAQ:<a href="https://investorplace.com/stock-quotes/auvi-stock-quote/">AUVI</a>) stock is slipping more than 13% despite <a href="https://www.nasdaq.com/press-release/applied-uv-inc.-announces-receipt-of-significant-orders-in-smart-building">announcing significant orders</a>.</li>



<li>Safe &amp; Green (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgbx-stock-quote/">SGBX</a>) shares close out our pre-market stock movers down over 12%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-jan-16th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time for a breakdown of the biggest pre-market stock movers for Wednesday morning as we check out all of the latest news today!



Moving stocks this morning are a canceled dividend, expanded partnership, proposed public offering and more.



Let&rsquo;s dive into that new



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Meta Materials (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmat-stock-quote/">MMAT</a>) stock is rocketing more than 46% with extremely heavy trading this morning.</li>



<li>RiskOn International (NASDAQ:<a href="https://investorplace.com/stock-quotes/roi-stock-quote/">ROI</a>) shares are soaring over 33% alongside incredibly strong pre-market trading.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) stock is surging close to 24% with heavy early morning trading today.</li>



<li>Solid Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sldp-stock-quote/">SLDP</a>) shares are gaining more than 12% after <a href="https://www.nasdaq.com/press-release/solid-power-and-sk-on-deepen-partnership-with-new-agreements-2024-01-16">announcing an expanded partnership</a>.</li>



<li>LQR House (NASDAQ:<a href="https://investorplace.com/stock-quotes/lqr-stock-quote/">LQR</a>) stock is increasing over 12% after falling yesterday on <a href="https://www.marketwatch.com/story/lqr-house-shares-tumble-after-board-scotches-special-dividend-815a8378">canceled special dividend plans</a>.</li>



<li>Vertical Aerospace (NYSE:<a href="https://investorplace.com/stock-quotes/evtl-stock-quote/">EVTL</a>) shares are rising more than 12% on Wednesday morning.</li>



<li>Ocean Biomedical (NASDAQ:<a href="https://investorplace.com/cryptocurrency/ocea/">OCEA</a>) stock is jumping over 11% this morning.</li>



<li>Salarius Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/slrx-stock-quote/">SLRX</a>) shares are heading more than 10% on Wednesday.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is climbing over 9% this morning.</li>



<li>Direxion Daily FTSE China Bear 3x Shares (NYSEARCA:<a href="https://investorplace.com/stock-quotes/yinn-stock-quote/">YINN</a>) are up more than 9% as <a href="https://www.newsweek.com/china-stock-market-free-fall-1860933">China&rsquo;s stock market struggles</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Phunware (NASDAQ:<a href="https://investorplace.com/stock-quotes/phun-stock-quote/">PHUN</a>) stock is crashing over 59% <a href="https://investorplace.com/2024/01/why-is-phunware-phun-stock-up-57-today/">after a rally yesterday</a>.</li>



<li>DatChat (NASDAQ:<a href="https://investorplace.com/stock-quotes/dats-stock-quote/">DATS</a>) shares are plummeting more than 33% after announcing a <a href="https://www.nasdaq.com/press-release/datchat-inc.-announces-proposed-underwritten-public-offering-of-common-stock-2024-01">proposed public offering</a>.</li>



<li>Jin Medical International (NASDAQ:<a href="https://investorplace.com/stock-quotes/zjyl-stock-quote/">ZJYL</a>) stock is diving over 26% on Wednesday morning.</li>



<li>Remark (NASDAQ:<a href="https://investorplace.com/stock-quotes/mark-stock-quote/">MARK</a>) shares are tumbling more than 23% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317986980&amp;type=PDF&amp;symbol=MARK&amp;cdn=f4b35749b19aaa576f006dcd691865f9&amp;companyName=Remark+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-01-16">amending a purchase agreement</a>. </li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) stock is taking an over 15% beating on Wednesday morning.</li>



<li>Cemtrex (NASDAQ:<a href="https://investorplace.com/stock-quotes/cetx-stock-quote/">CETX</a>) shares are sliding more than 13% this morning.</li>



<li>Spirit Airlines (NYSE:<a href="https://investorplace.com/stock-quotes/save-stock-quote/">SAVE</a>) stock is decreasing over 13% after its <a href="https://www.cnbc.com/2024/01/16/jetblue-spirit-merger-block-in-win-for-bidens-justice-department.html">merger plans were blocked</a>.</li>



<li>Garden Stage (NASDAQ:<a href="https://investorplace.com/stock-quotes/gsiw-stock-quote/">GSIW</a>) shares are dropping more than 12% on Wednesday morning.</li>



<li>Atreca (NASDAQ:<a href="https://investorplace.com/stock-quotes/bcel-stock-quote/">BCEL</a>) stock is declining over 12% today.</li>



<li>Adagene (NASDAQ:<a href="https://investorplace.com/stock-quotes/adag-stock-quote/">ADAG</a>) shares close out our pre-market stock movers down more than 10% alongside <a href="https://www.nasdaq.com/press-release/adagene-presents-interim-results-reinforcing-best-in-class-profile-of-masked-anti">interim clinical trial results</a>.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT766529">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/01/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-jan-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Atreca Inc (BCEL) is around the top of the Healthcare sector according to InvestorsObserver.BCEL received an overall rating of 36, which means that it scores higher than 36% of stocks. Additionally, Atreca Inc scored a 72 in the Healthcare sector, ranking it higher than 72% of stocks in that sector. BCEL has an Overall Sco

Is Atreca Inc (BCEL) Stock a Good Value Friday?

Atreca Inc (BCEL) has released an update to notify the public and investors about its officers. As Atreca, Inc. scales down operations, Dr. Tito A....

Atreca Inc Announces Executive Departures and Consulting Agreements

ADAG

ATNF

AULT

AUVI

AVTX

BJDX

BOIL

BURU

CETX

CMND

CRGE

CYTO

EKSO

EVTL

GBNH

GSIW

GWAV

IBTI

KOLD

KTRA

KYMR

MARK

MLEC

MMAT

MRDB

MSAI

MSOX

MULN

NEPT

NUBI

OCEA

OCTO

PAVM

QLGN

REPL

RVSN

SAVE

SERA

SGBX

SLDP

SLRX

SVMH

TCTM

TGAN

VYNE

XCUR

YINN

ZAPP

ZJYL

Press Releases

Intelligent Bio Solutions Inc. (NASDAQ: INBS): "Fingerprint Sweat Analysis: Revolutionizing Drug Screening with Speed and Precision" (JAGX, BCEL, CDIO)

Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives

Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome

Immunome to Acquire Antibody-Related Assets and Materials from Atreca

BCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.

Opinion

Thinking about buying stock in Carrols Restaurant Group, Atreca Inc, Energy Transfer, Agenus, or Recursion Pharmaceuticals?

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BCEL, CTLT, NS, SCX

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Atreca Inc Class A

Atreca Inc Class A (BCEL) Forecast

Atreca Inc Class A (OTC:BCEL) Stock, Quote.Headers.trade-ideas